当前位置:首页 - 行情中心 - 福元医药(601089) - 财务分析 - 现金流量表

福元医药

(601089)

  

流通市值:132.43亿  总市值:132.43亿
流通股本:4.80亿   总股本:4.80亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,416,292,559.891,579,528,111.81812,903,163.513,345,730,645.32
  收到的税费返还721,226.14721,226.14-2,160,950
  收到其他与经营活动有关的现金40,871,022.621,978,322.1312,607,024.35122,837,895.1
  经营活动现金流入小计2,457,884,808.631,602,227,660.08825,510,187.863,470,729,490.42
  购买商品、接受劳务支付的现金433,716,613.43282,064,387.68137,688,317.72554,280,613.38
  支付给职工以及为职工支付的现金512,862,659.8358,050,620.89223,166,935.6635,436,871.84
  支付的各项税费264,713,801.07196,214,203.9988,692,395.63313,712,605.64
  支付其他与经营活动有关的现金932,420,005.06547,867,439.84249,963,999.441,276,547,804.64
  经营活动现金流出小计2,143,713,079.361,384,196,652.4699,511,648.392,779,977,895.5
  经营活动产生的现金流量净额314,171,729.27218,031,007.68125,998,539.47690,751,594.92
二、投资活动产生的现金流量:
  收回投资收到的现金--20,000,000-
  取得投资收益收到的现金16,642,246.7813,873,096.779,320,167.5211,865,617.87
  处置固定资产、无形资产和其他长期资产收回的现金净额555,186.55114,086.5519,161.551,368,822.05
  收到的其他与投资活动有关的现金7,290,000,0005,302,000,0002,395,000,0002,413,998,981.92
  投资活动现金流入小计7,307,197,433.335,315,987,183.322,424,339,329.072,427,233,421.84
  购建固定资产、无形资产和其他长期资产支付的现金346,089,558.6297,752,386.58226,210,936.26391,523,374.16
  支付其他与投资活动有关的现金6,109,800,0004,154,000,0001,996,000,0004,050,300,448
  投资活动现金流出小计6,455,889,558.64,451,752,386.582,222,210,936.264,441,823,822.16
  投资活动产生的现金流量净额851,307,874.73864,234,796.74202,128,392.81-2,014,590,400.32
三、筹资活动产生的现金流量:
  取得借款收到的现金---49,900,000
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---49,900,000
  偿还债务支付的现金40,000,00040,000,00030,000,00082,203,678.81
  分配股利、利润或偿付利息支付的现金234,241,491.67234,241,491.67177,283.34236,592,212.58
  支付其他与筹资活动有关的现金16,181,811.7610,449,698.617,076,038.57198,005,863.64
  筹资活动现金流出小计290,423,303.43284,691,190.2837,253,321.91516,801,755.03
  筹资活动产生的现金流量净额-290,423,303.43-284,691,190.28-37,253,321.91-466,901,755.03
五、现金及现金等价物净增加额875,056,300.57797,574,614.14290,873,610.37-1,790,740,560.43
  加:期初现金及现金等价物余额713,759,803.65713,759,803.65713,759,803.652,504,500,364.08
  期末现金及现金等价物余额1,588,816,104.221,511,334,417.791,004,633,414.02713,759,803.65
补充资料:
  净利润-268,472,085.54-492,077,598.39
  资产减值准备-4,085,112.27-10,682,920.78
  固定资产和投资性房地产折旧-43,538,863.54-71,933,097.27
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-43,538,863.54-71,933,097.27
  无形资产摊销-6,580,177.16-12,167,542.16
  长期待摊费用摊销-4,066,452.43-5,185,097.8
  处置固定资产、无形资产和其他长期资产的损失-35,004.55--1,037,530.39
  固定资产报废损失-559,445.43-2,753,967.75
  财务费用-939,165.49-3,520,928.56
  投资损失--13,087,827.13--11,193,979.12
  递延所得税--12,798,187.08--3,395,757.81
  其中:递延所得税资产减少-284,470.69--500,167.37
    递延所得税负债增加--13,082,657.77--2,895,590.44
  存货的减少--16,767,055.63--50,819,027.82
  经营性应收项目的减少--4,535,638.12--28,570,338.42
  经营性应付项目的增加--72,068,066-169,620,264.71
  其他--494,469.82--1,357,708.15
  现金的期末余额-1,511,334,417.79-713,759,803.65
  减:现金的期初余额-713,759,803.65-2,504,500,364.08
  现金及现金等价物的净增加额-797,574,614.14--1,790,740,560.43
公告日期2025-10-302025-08-192025-04-302025-04-01
审计意见(境内)标准无保留意见
TOP↑